KKR & Co. Inc.는 민간자본과 부동산에 깊이 관여하는, 세계적으로 두각을 나타내는 투자 강자입니다. 이 회사의 다양한 투자 전략에는 직접 자본을 투입하는 방식뿐 ...
글로벌 투자회사 KKR은 Amwins Group 및 Dragoneer Investment와 함께 호주 보험 중개사 Steadfast를 인수하기 위한 77억 호주달러(53.3억 달러) 규모 제안에 미국 컨소시엄으로 합류했다. KKR은 Dragoneer와 함께 공동 리드 투자 파트너로 나서며, Dragoneer는 Steadfast의 소매 브로커리지 사업에 대한 지배권을 가져갈 계획이다. 한편 Amwins는 언더라이팅 에이전시 운영을 인수한다. 6월에 처음 제시된 Steadfast 주당 6호주달러의 컨소시엄 제안은 그대로 유지되며, KKR의 참여는 딜의 일정에 영향을 주지 않을 전망이다.
BridgeBio Pharma의 이사인 Jennifer E. Cook은 주식매수선택권을 행사한 뒤 합계 1,316만 달러 규모의 주식을 매각했으며, 그 결과 순수 직접 보유 주식은 8,383주가 됐다. 이번 거래들은 Rule 10b5-1 매각 계획의 일부였다. 회사 주가는 52주 신고가에 근접한 수준에서 거래 중이며 지난 1년간 85%의 수익률을 보였지만, InvestingPro는 이를 약간 과대평가된 것으로 보고 있다.
BridgeBio Pharma의 이사 Andrea Ellis는 2026년 7월 9일, 2025년 12월 채택된 Rule 10b5-1 매각 계획의 일환으로 회사 보통주 144만 달러어치를 매각했다. 이번 거래는 주당 16.75달러에 17,167주에 대한 주식매수선택권을 행사한 데 따른 것이다. 주가는 현재 52주 신고가에 근접해 거래 중이며, InvestingPro는 이를 약간 과대평가된 것으로 시사한다.
Williams(NYSE: WMB)는 Blackstone으로부터 약 53.4억 달러 규모 투자를 발표했으며, Apollo 및 KKR과의 파트너십을 통해 자사 5개 Power Innovation 프로젝트에 대한 지분 49%의 비지배(Noncontrolling) 지분을 확보하게 된다. 이 자본은 Socrates 및 Apollo 같은 프로젝트의 성장을 뒷받침하고 수익을 높이는 데 사용된다. 한편 Williams는 51% 소유권과 운영 통제권을 유지한다. 이번 거래는 Williams의 자본 노출을 줄이고, 기업 부채를 제한하며, 6+ GW 규모 프로젝트 잔고를 제공하는 데 도움을 주어 회사의 장기 레버리지 목표 달성을 지원하는 것을 목표로 한다.
캐나다왕립은행은 KKR & Co. Inc. (NYSE:KKR)의 목표주가를 $128에서 $125로 낮추면서도 "시장수익률 상회(outperform)" 등급은 유지했으며, 여전히 30%의 상승 여력을 시사했다. 이러한 조정에도 불구하고 KKR은 "매수(Moderate Buy)" 컨센서스 등급을 유지하고 있으며, 애널리스트들 사이의 평균 목표주가는 $132.08이다. KKR은 최근 5억 달러 규모의 자기주식 환매 계획을 승인했으며, 분기 EPS는 $1.24, 매출은 57억 4,000만 달러를 기록했다고 밝혔다.
글로벌 투자회사 KKR은 Amwins Group 및 Dragoneer Investment와 함께 호주 보험 중개사 Steadfast를 인수하기 위한 77억 호주달러(53.3억 달러) 규모 제안에 미국 컨소시엄으로 합류했다. KKR은 Dragoneer와 함께 공동 리드 투자 파트너로 나서며, Dragoneer는 Steadfast의 소매 브로커리지 사업에 대한 지배권을 가져갈 계획이다. 한편 Amwins는 언더라이팅 에이전시 운영을 인수한다. 6월에 처음 제시된 Steadfast 주당 6호주달러의 컨소시엄 제안은 그대로 유지되며, KKR의 참여는 딜의 일정에 영향을 주지 않을 전망이다.
BridgeBio Pharma의 이사인 Jennifer E. Cook은 주식매수선택권을 행사한 뒤 합계 1,316만 달러 규모의 주식을 매각했으며, 그 결과 순수 직접 보유 주식은 8,383주가 됐다. 이번 거래들은 Rule 10b5-1 매각 계획의 일부였다. 회사 주가는 52주 신고가에 근접한 수준에서 거래 중이며 지난 1년간 85%의 수익률을 보였지만, InvestingPro는 이를 약간 과대평가된 것으로 보고 있다.
BridgeBio Pharma의 이사 Andrea Ellis는 2026년 7월 9일, 2025년 12월 채택된 Rule 10b5-1 매각 계획의 일환으로 회사 보통주 144만 달러어치를 매각했다. 이번 거래는 주당 16.75달러에 17,167주에 대한 주식매수선택권을 행사한 데 따른 것이다. 주가는 현재 52주 신고가에 근접해 거래 중이며, InvestingPro는 이를 약간 과대평가된 것으로 시사한다.
Williams(NYSE: WMB)는 Blackstone으로부터 약 53.4억 달러 규모 투자를 발표했으며, Apollo 및 KKR과의 파트너십을 통해 자사 5개 Power Innovation 프로젝트에 대한 지분 49%의 비지배(Noncontrolling) 지분을 확보하게 된다. 이 자본은 Socrates 및 Apollo 같은 프로젝트의 성장을 뒷받침하고 수익을 높이는 데 사용된다. 한편 Williams는 51% 소유권과 운영 통제권을 유지한다. 이번 거래는 Williams의 자본 노출을 줄이고, 기업 부채를 제한하며, 6+ GW 규모 프로젝트 잔고를 제공하는 데 도움을 주어 회사의 장기 레버리지 목표 달성을 지원하는 것을 목표로 한다.
캐나다왕립은행은 KKR & Co. Inc. (NYSE:KKR)의 목표주가를 $128에서 $125로 낮추면서도 "시장수익률 상회(outperform)" 등급은 유지했으며, 여전히 30%의 상승 여력을 시사했다. 이러한 조정에도 불구하고 KKR은 "매수(Moderate Buy)" 컨센서스 등급을 유지하고 있으며, 애널리스트들 사이의 평균 목표주가는 $132.08이다. KKR은 최근 5억 달러 규모의 자기주식 환매 계획을 승인했으며, 분기 EPS는 $1.24, 매출은 57억 4,000만 달러를 기록했다고 밝혔다.
윌리엄스(WMB)는 블랙스톤이 이끄는 컨소시엄으로부터 53.4억 달러 투자를 받게 될 예정이며, 이 컨소시엄에는 아폴로와 KKR이 운용하는 관련 엔터티가 포함된다. 이번 투자는 5개 전력 인프라 프로젝트에 자금을 투입하기 위한 것으로, 블랙스톤과 파트너들은 이들 프로젝트에 대해 49%의 비지배(비계열) 지분을 인수한다. 블랙스톤의 목표 수익률을 초과하는 분배금은 투자 잔액을 줄이게 된다.
윌리엄스(WMB)는 아폴로를 포함한 블랙스톤 주도 그룹으로부터 53.4억 달러의 투자를 발표했으며, 이는 파워 혁신(Power Innovation) 합작투자의 5개 계통 외(behind-the-meter) 전력 발전 프로젝트에 대한 49% 지분을 확보하기 위한 것이다. 이 소식은 윌리엄스 주식이 장 초반 1.7% 하락하는 데 영향을 줬다. 이번 투자는 블랙스톤과 아폴로가 참여한다.
미국 파이프라인 운영사 윌리엄스는 블랙스톤이 이끄는 컨소시엄으로부터 53.4억 달러 투자를 확보했다. 이번 투자로 컨소시엄은 윌리엄스의 계통 외 전력 발전 프로젝트 5곳에 대해 49%의 비지배 지분을 갖게 된다. 자금은 성장 관련 설비투자에 44억 달러가 포함되며, 여기에 윌리엄스를 위한 추가 9억 달러가 더해진다.
U.S. pipeline operator Williams Companies Inc (WMB.N) announced that a consortium led by Blackstone (BX.N), including Apollo and KKR, will invest $5.34 billion for a 49% noncontrolling stake in five of its power generation projects. This investment includes $4.4 billion for growth capital expenditures and an additional $900 million to Williams. The transaction covers the Socrates, Apollo, Aquila, Socrates the Younger, and Neo projects, which are part of a larger portfolio of over 6 gigawatts of power projects being developed by Williams.
BMO Capital Markets has reduced its price target for KKR & Co. Inc. (NYSE:KKR) to $112.00 from $120.00, while maintaining an "outperform" rating, which still suggests a 15.52% upside from the current stock price. Despite this reduction, the consensus analyst rating remains a "Moderate Buy" with an average target price of $132.31. KKR recently authorized a $500 million share repurchase program and reported quarterly EPS of $1.24 and revenue of $5.74 billion.
The Williams Companies, Inc. (WMB) has reported a material event in an 8-K filing, announcing a joint venture financing agreement for its five Power Innovation projects. Blackstone Credit & Insurance, in partnership with Apollo and KKR, will provide $5.34 billion in committed capital for a 49% noncontrolling equity interest in these projects, including Socrates, Apollo, Aquila, Socrates the Younger, and Neo. Williams will retain a 51% interest and operational control, with the deal structured to provide efficient equity capital, reduce capital exposure, and maintain the company's financial flexibility, supporting its 2026 Adjusted EBITDA guidance and an updated leverage midpoint.
Williams (NYSE: WMB) has secured a $5.34 billion investment from Blackstone, in partnership with Apollo and KKR, for a 49% noncontrolling equity interest in five of its Power Innovation projects. This strategic partnership provides Williams with efficient equity capital to fund project growth, reduces capital exposure, and helps maintain its long-term leverage target. The investment highlights the value of Williams' energy infrastructure platform and supports the advancement of its 6+ GW backlog in power innovation.
The author is avoiding FS KKR Capital (FSK) due to several concerns, including a 50% stock price drop and surging non-accruals indicating deteriorating credit quality. Despite dividend cuts, coverage remains weak, and structural risks, concentrated exposures, and declining NAV outweigh a deep P/BV valuation, raising the risk of further cuts.
Barclays has increased its price target for American Electric Power (NASDAQ: AEP) to $138 from $136, while retaining an Equalweight rating on the stock. This adjustment reflects an updated outlook from the financial institution on the utility company's valuation. The report was issued on July 13, 2026, by MT Newswires.
Piper Sandler has increased its price target for SEI Investments (NASDAQ:SEIC) to $114 from $105, maintaining an Overweight rating due to strong Q1 momentum and significant mandate wins in its Investment Managers segment. The firm anticipates continued sales growth and operating margins exceeding 30%. KKR was also highlighted as a top pick, with strong fundamentals and strategic developments, despite a turbulent macro-environment.
Williams (WMB) shares rose after the company announced a $5.34 billion investment from Blackstone Credit & Insurance, Apollo, and KKR. This partnership involves the consortium acquiring a 49% noncontrolling equity interest in five major power projects, providing long-term funding and reducing Williams' capital commitments. Williams will retain a 51% stake and operational control, with the funding supporting the expansion of its Power Innovation portfolio while maintaining its financial guidance.
Evercore ISI has revised its price target for KKR & Co. Inc. (KKR) to $115, down from $119, while reaffirming an Outperform rating on the stock. This adjustment reflects the outlook of the analyst firm on the investment management company. The article, originating from MT Newswires, provides this specific analyst rating update for KKR & Co. Inc.
BMO Capital has revised its price target for KKR & Co. (KKR) to $112, down from $120, while reaffirming its "Outperform" rating on the investment management firm. The adjustment was reported on July 13, 2026, by MT Newswires, indicating an updated valuation for the company from the analyst firm.
Midwest Trust Co increased its holdings in KKR & Co. Inc. by 10.8% in the first quarter, bringing its total to 141,805 shares valued at $13.1 million. Institutional investors now own 76.26% of KKR's stock, and analysts maintain a "Moderate Buy" rating with an average target price of $131.85. KKR also recently raised its quarterly dividend and authorized a $500 million share repurchase program, indicating confidence from the board.
IFC Advisors LLC significantly increased its stake in KKR & Co. Inc. by 378.7% in the first quarter, now holding 69,569 shares valued at $6.43 million. Analysts have given KKR a "Moderate Buy" rating with a consensus price target of $131.85. The company recently raised its quarterly dividend to $0.195 per share and authorized a $500 million share buyback, indicating strong confidence in its value.
KKR is moving to acquire EDF power solutions North America for an estimated $4.2 billion, with potential additional payments amidst challenges in the renewable energy market in the US and Canada. These challenges include political opposition, grid-interconnection backlogs, and supply-chain issues, yet KKR remains optimistic, particularly about solar energy opportunities. The acquisition is expected to close in the latter half of 2026, bolstering KKR's significant investments in renewable and energy transition projects globally.
InterContinental Hotels Group (IHG) repurchased 40,000 ordinary shares on July 10, 2026, through Goldman Sachs International on the London Stock Exchange. The shares were bought at an average price of $164.1698, totaling approximately $6.57 million, and IHG intends to cancel them. This transaction leaves the company with 148,655,326 ordinary shares in issue, excluding shares held in treasury.
Australian oil refiner Ampol Ltd. secured a A$400 million ($277 million) private credit loan from KKR & Co., with support from Clifford Capital. The loan, a cornerstone investment by KKR’s Asia Pacific credit strategy, will be used to refinance existing debt and for general corporate purposes. The deal highlights the growing role of private credit in corporate financing.
KKR, a global investment firm, has announced its lead investment in a A$400 million (US$275 million) financing solution for Ampol Limited, an ASX-listed integrated fuel supply and marketing company in Australia. This investment, supported by KKR's private credit and insurance platforms, will help Ampol with its refinancing initiatives and general corporate purposes. The partnership highlights KKR's commitment to providing flexible capital to high-quality companies in the Asia Pacific region, leveraging Clifford Capital's expertise in arranging the transaction.
Castleview Partners LLC increased its stake in KKR & Co. Inc. by 84.5% during the first quarter, now owning 36,761 shares valued at $3.4 million. KKR's stock, trading near $96.95, has a market cap of $87.05 billion and a "Moderate Buy" consensus rating with an average target price of $131.85 from analysts. The company also raised its quarterly dividend to $0.195 per share and initiated a $500 million share repurchase plan.
Swedbank AB decreased its stake in KKR & Co. Inc. by 18.4% during the first quarter, selling 17,374 shares and reducing its total holdings to 77,064 shares valued at $7.13 million. Despite this, other major institutional investors like Vanguard Group Inc. and Geode Capital Management LLC increased their positions. KKR's stock saw a positive trading day, rising 0.7%, and the company recently announced a dividend increase and a $500 million share buyback authorization.
Haven Capital Group strategically shifted its portfolio in Q1 2026, investing in Vistra Corp. (VST) while divesting from Vertiv Holdings Co (VRT). This move reflects a preference for Vistra's direct, contracted role in providing power for AI infrastructure over Vertiv's broader digital equipment exposure. Vistra's strong partnerships, stable revenue streams through long-term power purchase agreements, and attractive forward valuation compared to Vertiv, have positioned the company as a key player in the energy-intensive AI economy, despite risks like significant debt and regulatory uncertainties.
Private equity firms like Blackstone, Blue Owl Capital, and KKR are heavily investing in AI infrastructure, including data centers and power generation, as they anticipate that owning these foundational assets will be crucial for the AI boom. This strategy stems from the understanding that while AI models are a focus, the underlying infrastructure presents a more stable, long-term investment given the increasing compute costs and demands. These firms are positioning themselves to capitalize on the ongoing need for robust digital infrastructure, regardless of which specific AI models become dominant.
Sempra has announced Justin Bird's appointment as executive vice president and chief financial officer, effective around the closing date of Sempra’s planned sale of a 45% stake in Sempra Infrastructure Partners to KKR. Bird, a 20-year Sempra veteran, will expand his oversight to include accounting, investor relations, treasury, financial planning, audit, insurance, and tax functions. His extensive experience in project finance, corporate development, and leadership roles at Sempra Infrastructure positions him to support Sempra's mission to become America's leading utility growth business.
Barclays has raised its price target for KKR & Co. Inc. (NYSE:KKR) to $124.00, maintaining an "overweight" rating and suggesting a 29% upside. While other analysts have offered mixed revisions, KKR retains a "Moderate Buy" consensus. The company recently authorized a $500 million share repurchase plan and reported strong Q4 2025 earnings of $1.24 EPS on $5.74 billion in revenue.
KKR & Co. (KKR) is expected to report its fiscal second-quarter earnings for 2026 before the market opens on July 30, with analysts forecasting a profit of $1.23 per share, a 23% increase year-over-year. Despite a "Strong Buy" consensus from analysts and a potential upside of 28.4%, KKR stock has underperformed the S&P 500 and the XLF ETF over the past 52 weeks. The firm reported strong Q1 results with adjusted EPS up 20.9% and fee-related earnings rising 23.6%.
The article lists the top holdings of the Tema Alternative Asset Managers ETF (PRVT) as of July 2, 2026. It details the symbol, weight, shares, and market value for each of the top ten companies within the ETF. Companies such as Brookfield Corporation, Apollo Global Management Inc., and Blackstone Inc. are among the largest constituents.
Barclays has increased its price target for KKR & Co. Inc. to $124 from $122, maintaining
SK Telecom responded to media reports concerning a potential Won 1 trillion capital increase and KKR's equity investment in an AI data center project. The company stated that while it is exploring strategic options for its AI data center business, no specific decisions have been made yet. SK Telecom committed to providing further disclosure within one month or when decisions are finalized.
Barclays has increased its price target for KKR & Co. Inc. (KKR) to $124 from the previous $122. This adjustment reflects an updated outlook by the financial institution on the investment management company's stock. KKR's stock closed at $96.27 on July 9, 2026.
The PRVT Stock Fund, also known as the Tema Alternative Asset Managers ETF (BOATS:PRVT), is an actively managed exchange-traded fund that focuses on companies deriving at least 50% of their revenues from alternative assets. With an inception date of October 1, 2025, and assets under management of $1.21 million USD, the fund invests in approximately 15 to 100 companies based on fundamental analysis and growth potential, and it has an expense ratio of 0.75%.
KKR Income Opportunities Fund (NYSE:KIO) is scheduled to go ex-dividend on July 10th, 2026. Shareholders as of that date will be eligible to receive a dividend of 0.1215 USD per share. This declaration signals an upcoming distribution to investors in the fund.
Sempra has announced key leadership appointments to advance its strategic priorities, including Justin Bird becoming Executive Vice President and Chief Financial Officer of Sempra, and Karen Sedgwick becoming CEO and President of Southern California Gas Company (SoCalGas). These changes are anticipated to be effective around the closing of Sempra's planned sale of a 45% stake in Sempra Infrastructure Partners to affiliates of KKR, expected in Q3 2026. The appointments aim to bolster leadership continuity, talent development, and strengthen the company's financial position by concentrating investment in regulated U.S. utility operations.
BridgeBio Pharma (BBIO) shares surged over 15% following positive Phase 3 trial results for its drug infigratinib in pediatric achondroplasia, which also secured publication in the New England Journal of Medicine. The company plans FDA and EMA filings in 2026 for a potential U.S. launch in early-mid 2027. Additionally, BridgeBio raised $1 billion in convertible preferred equity, strengthening its financial position for upcoming product launches and pipeline growth.
FS KKR Capital (NYSE:FSK) announced it will release its second-quarter 2026 results on Thursday, August 6, 2026, before market open, and will host a live webcast conference call at 9:00 a.m. Eastern Time on the same day. Investors and analysts can find webcast and registration details, along with an investor presentation, on the "For Investors" section of FSK's website. The article also provides historical context of FSK and KKR related news and financial details.
FS KKR Capital Corp. (FSK) announced its plan to release second-quarter 2026 results before the New York Stock Exchange opens on Thursday, August 6, 2026. FSK will also host a live webcast conference call on the same day at 9:00 a.m. Eastern Time. Investors and analysts can access information and register for the call via FSK's website.
This article lists the top holdings of the Tema Alternative Asset Managers ETF (PRVT) as of July 2, 2026. Key holdings include Brookfield Corporation, Apollo Global Management Inc, Blackstone Inc., and KKR & Co Inc, with their respective weight percentages, shares, and market values. The ETF provides exposure to a range of alternative asset management companies.
This page provides live stock quotes and charts for KKR & Co. Inc. (KKR), along with general information about the company. It briefly mentions the current stock price and change but notes a lack of analyst ratings and earnings information. The article primarily serves as a placeholder page with disclaimers about the risks of day trading, citing several studies on trader profitability.
KKR is set to acquire the North American operations of EDF power solutions, a clean energy affiliate of French utility EDF group, for $4.2 billion, with potential additional payments up to $390 million. This acquisition, announced on June 30, aligns with KKR's goal to support U.S. energy security and affordability amidst rising electricity demand. EDF power solutions operates a significant portfolio of solar, wind, and battery storage assets, ranking among the top 10 renewable capacity owners in the United States.
BridgeBio Pharma (BBIO) shares jumped over 13% following positive Phase 3 clinical trial results for its oral infigratinib in pediatric achondroplasia, which showed statistically significant improvements in body proportionality and arm span. The company also secured up to $1 billion in Series A convertible preferred equity, strengthening its financial position to fund Attruby and anticipate three U.S. product launches. These developments have boosted investor confidence despite a recent insider stock sale.
KKR & Co. Inc. (KKR) shares rose 3.18% to $96.27, outperforming the broader market. This gain snapped a two-day losing streak for the company. The S&P 500 Index and Dow Jones Industrial Average also saw gains on a strong trading day.
Sempra has announced key leadership appointments to strengthen its utility growth business. Karen Sedgwick will become CEO and President of SoCalGas, while Justin Bird will take on the role of Executive Vice President and CFO of Sempra. These changes are aligned with the company's strategy to divest a 45% stake in Sempra Infrastructure Partners and focus on its regulated U.S. utility operations in Texas and California.
The article analyzes the Virtus InfraCap U.S. Preferred Stock ETF (PFFA), highlighting its 8.5% yield achieved through leverage and preferred stock coupons. It discusses the durability of this yield, noting that falling Fed funds rates lower borrowing costs, but warns that the leverage introduces volatility and makes it unsuitable for investors prioritizing stable principal. The author concludes that PFFA's distribution appears safe for the next twelve months due to investment-grade issuers and falling borrowing costs, despite the inherent NAV volatility.
BridgeBio Pharma (BBIO) shares jumped over 15% after its Phase 3 PROPEL 3 trial for oral infigratinib in children with achondroplasia met primary and secondary endpoints, showing significant improvement in body proportionality and arm span. The company also secured up to $1 billion in Series A convertible preferred equity to fund multiple launches, including Attruby. BBIO plans FDA and EMA filings in 2026, targeting a U.S. launch for infigratinib in early to mid-2027.
Diagnostics company Qiagen is reportedly attracting takeover interest from buyout firms including EQT AB, Advent, and KKR, with potential offers reaching at least $50 per share. This news, initially reported by Bloomberg, caused Qiagen's shares in Frankfurt to rise by at least 10%. The Netherlands-based company has a market value of €6.87 billion, and previous reports indicated Qiagen was exploring strategic alternatives.
